Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tanswell

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Arzneimittel-Forschung|November 1, 1989
Current developments in thrombolytic therapy using novel plasminogen activatorsE Seifried, P Tanswell
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis programP Tanswell, J Koup
Arzneimittel-Forschung|May 1, 1989
Properties of molecular variants of tissue-type plasminogen activatorJ Krause, P Tanswell
Thrombosis and Haemostasis|October 28, 1987
Comparison of specific antibody, D-Phe-Pro-Arg-CH2Cl and aprotinin for prevention of in vitro effects of recombinant tissue-type plasminogen activator on haemostasis parametersE Seifried, P Tanswell
Journal of Immunological Methods|November 6, 1986
Automated monoclonal radioimmunoassays for pirenzepine, a selective muscarinic receptor antagonist, in plasma and urineP Tanswell, W Kasper, G Zahn
European Journal of Biochemistry|August 1, 1978
Structure of antigenic determinants in the amino-terminal region of bovine fibrinogen Aalpha chainP Tanswell, H Reiter, R Timpl
Arzneimittel-Forschung|October 1, 1988
Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmosetA Greischel, P Tanswell, U Busch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolismU Tebbe, E Seifried, J Carlsson, et al.
European Journal of Biochemistry|March 16, 1976
Nuclear-magnetic-resonance study of the active-site structure of yeast phosphoglycerate kinaseP Tanswell, E W Westhead, R J Williams
Arzneimittel-Forschung|December 1, 1991
Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activatorP Tanswell, E Seifried, E Stang, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Arzneimittel-Forschung|November 1, 1989
Current developments in thrombolytic therapy using novel plasminogen activatorsE Seifried, P Tanswell
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis programP Tanswell, J Koup
Arzneimittel-Forschung|May 1, 1989
Properties of molecular variants of tissue-type plasminogen activatorJ Krause, P Tanswell
Thrombosis and Haemostasis|October 28, 1987
Comparison of specific antibody, D-Phe-Pro-Arg-CH2Cl and aprotinin for prevention of in vitro effects of recombinant tissue-type plasminogen activator on haemostasis parametersE Seifried, P Tanswell
Journal of Immunological Methods|November 6, 1986
Automated monoclonal radioimmunoassays for pirenzepine, a selective muscarinic receptor antagonist, in plasma and urineP Tanswell, W Kasper, G Zahn
European Journal of Biochemistry|August 1, 1978
Structure of antigenic determinants in the amino-terminal region of bovine fibrinogen Aalpha chainP Tanswell, H Reiter, R Timpl
Arzneimittel-Forschung|October 1, 1988
Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmosetA Greischel, P Tanswell, U Busch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1992
Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolismU Tebbe, E Seifried, J Carlsson, et al.
European Journal of Biochemistry|March 16, 1976
Nuclear-magnetic-resonance study of the active-site structure of yeast phosphoglycerate kinaseP Tanswell, E W Westhead, R J Williams
Arzneimittel-Forschung|December 1, 1991
Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activatorP Tanswell, E Seifried, E Stang, et al.
Pageof 4